VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways-Reference-Cited by-同舟云学术

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways

Published:2018-08-23 Issue:19 Volume:175 Page:3813-3831
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

del Rio Carmen¹²³,Cantarero Irene¹²³,Palomares Belén¹²³,Gómez-Cañas María⁴⁵⁶,Fernández-Ruiz Javier⁴⁵⁶^ORCID,Pavicic Carolina⁷,García-Martín Adela⁸,Luz Bellido Maria⁸⁹,Ortega-Castro Rafaela¹²³,Pérez-Sánchez Carlos¹²³,López-Pedrera Chary¹²³,Appendino Giovanni¹⁰,Calzado Marco A¹²³,Muñoz Eduardo¹²³^ORCID

Affiliation:

1. Maimonides Biomedical Research Institute of Córdoba; University of Córdoba; Córdoba Spain

2. Department of Cellular Biology, Physiology and Immunology; University of Córdoba; Córdoba Spain

3. Reina Sofía University Hospital; Córdoba Spain

4. Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina; Universidad Complutense; Madrid Spain

5. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED); Madrid Spain

6. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); Madrid Spain

7. Innohealth Group; Madrid Spain

8. Vivacell Biotechnology; Córdoba Spain

9. Emerald Health Pharmaceuticals; San Diego CA USA

10. Dipartimento di Scienze del Farmaco; Università del Piemonte Orientale; Novara Italy

Funder

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad

Publisher

Wiley

Subject